|
Center Laboratories, Inc. is a professional investment holding company that transitioned from its origins in the pharmaceutical industry in 1959. The firm provides capital support, corporate restructuring, strategic planning, talent training, technology incubation, and market expansion services to portfolio companies. Its investment portfolio spans the biotechnology and healthcare sectors, including infant formula and nutritional products, clinical-stage drug development for neurological and oncological conditions, and contract development and manufacturing organizations (CDMOs) specializing in biologics, antibody-drug conjugates, peptides, and oligonucleotides. The company also holds stakes in advanced orthopedic medical devices, functional probiotics, and hydrogen energy technology. Notable portfolio entities include Ausnutria, Lumosa Therapeutics, Yisheng Biotech, Fenghua Biotech, Yongxin Biotech, Dongyao Pharmaceutical, Jianyi Biotech, Shanghai Baoji Pharmaceutical, and Bosheng. The group also supports gene therapy ventures such as GenEditBio and hydrogen energy projects like Youmu Technology. Summarised from the company's own disclosures |
Industry Asset Management | Homepage centerlab.com.tw |
| Sector Financial Services | IR page centerlab.com.tw/investor | |
|
Tags
biotechnology, pharmaceuticals, cdmo, infant formula, gene therapy, hydrogen energy, medical devices, probiotics, oncology, neurology, Ausnutria, Jia Bei Ai Te, Lumosa Therapeutics, Yisheng Biotech, Fenghua Biotech, Yongxin Biotech, Dongyao Pharmaceutical, Jianyi Biotech, Shanghai Baoji Pharmaceutical, Bosheng, Ai Xi Kang, GenEditBio, Youmu Technology
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | NT$ 20.481B |
| Market cap (USD) | $ 621.633M |
| P/E | -14.09 |
| PEG | — |
| P/BV | 1.21 |
| P/S | 11.52 |
| P/OCF | 49.27 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 41.9% |
| ROI | 35.2% |
| ROIC | -1.1% |
| Profit margin | 614.9% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | 350.1% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -18.8% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.516B | 1.618B | 1.394B | 767.722M | 500.107M | 717.045M | 1.438B | 21.648B | 19.392B | 15.04B | 6.792B | 898.759M | 741.934M | 713.74M | 684.436M | 569.032M |
| Net profit | 9.323B | -1.104B | -995.421M | 102.216M | 1.816B | 3.786B | -286.4M | 6.084B | 249.998M | 19.455M | 421.502M | 333.262M | 51.911M | 99.852M | 42.556M | 12.964M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 41.6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/S | 20.48 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial information published on MOPS, newest first, subjects as filed in Chinese, guarantee and loan balance notices and routine equipment purchases included. The link opens the company's material information on MOPS. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Center Laboratories, Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.

圖說:晟德****水劑與特殊藥物一覽。/圖片提供/晟德大藥廠

